|
Baltimore's Profectus BioSciences receives $4.6M DOD grant to develop vaccine for Western, Eastern, and Venezuelan Equine Encephalitis viruses.
Gaithersburg's Wellstat receives FDA approval of VISTOGARD, the first antidote to treat overdoses and early-onset severe toxicities due to 5-FU and capecitabine chemotherapies.
Rockville's Therabron Therapeutics announces favorable infant outcomes with six-month follow-up of a phase 1b recombinant human CC10 (rhCC10) clinical trial.
Gaithersburg's Emergent BioSolutions receives FDA approval to expand the label of BioThrax® (Anthrax Vaccine Adsorbed) to include post-exposure prophylaxis (PEP).
Columbia's Medifocus, Inc. commercializing minimally invasive treatment systems used in treatment of cancerous and benign tumors, and BPH closes $785,000 financing.
Germantown's Intrexon working through subsidiary to reduce outbreak of mosquito borne Zika virus and related congenital birth defects in Brazil.
Baltimore's PathSensors receives contract from U.S. Dept. of Homeland Security for biosecurity including development of sensors to detect Ebola and Abrin.
UM Baltimore grants Baltimore's Pataigin, LLC, rights to technology developed for rapid, point-of-care identification of dangerous pathogens.
Baltimore's Sinai Hospital is the location of a new LifeBridge BioIncubator providing options for lab space from 90 to 320 square feet. The space will be available in early 2016.
Bethesda's RightEye says it's developed a game changer for diagnosing concussions.
Partial reimbursement for internships is available to biohealth technology companies which offer internship positions to MD Tech Connect's prescreened applicants.
The MD Department of Commerce makes market research resources--Frost and Sullivan, Recap, Medtrack and BioMedTracker--available to Maryland-based biohealth entrepreneurs at its offices in Baltimore and Rockville. Please schedule appointments in advance.
|
|
Upcoming Deadlines and Events
|
Exegi Pharma (Gaithersburg)
GSK (Rockville) To view more job opportunities,
please check at the bottom
US Pharmacopeia (Rockville) bottom of the MD COMMERCE BioHealth Technology website. |
|
BioHealth Technology Innovator Spotlight
|
|
FLAVORx's newest auto-flavoring prescription machine built by Harbor Designs which increases patient options and compliance while saving pharmacists time and reducing errors. |
The Maryland Department of Commerce focuses on attracting, retaining, and expanding businesses and creating jobs in Maryland, and also markets Maryland's many assets to companies across the nation and abroad.
The Department's Office of BioHealth Technology supports innovative start-ups and companies focused on animal and human health, health IT, research tools, and related technologies. These include those involving agricultural and marine bio, biodefense, therapeutics, vaccines, diagnostics, medical devices, biologics, nutraceuticals, personalized and regenerative medicine, digital health, mHealth, telemedicine, EHR, bioinformatics, health IT infrastructure, data center services, patient engagement, and wellness.
|
|
|
|
